Epiretinal membrane (ERM) is a common condition that affects the eyes of millions of people worldwide. It is a thin, transparent layer of tissue that forms on the surface of the retina, the light-sensitive layer of tissue at the back of the eye. ERM can cause a variety of vision problems, including blurred vision, reduced contrast sensitivity, and difficulty with night vision. In some cases, ERM can lead to permanent vision loss. Despite its prevalence, the exact cause of ERM is still not fully understood. In this article, we will explore the current understanding of ERM and discuss the latest advances in diagnosis and treatment.
Epiretinal membrane is a thin, transparent layer of tissue that forms on the surface of the retina. It is composed of collagen and other proteins, and is usually caused by the contraction of scar tissue that forms after a retinal tear or detachment. In some cases, ERM can be caused by an inflammatory process or a reaction to a surgical procedure. ERM can cause a variety of vision problems, including blurred vision, reduced contrast sensitivity, and difficulty with night vision. In some cases, ERM can lead to permanent vision loss.
ERM is typically diagnosed using a combination of physical examination, imaging tests, and other diagnostic techniques. During the physical examination, the doctor will look for signs of ERM, such as a retinal tear or detachment. Imaging tests, such as optical coherence tomography (OCT) and fluorescein angiography, can also be used to diagnose ERM. OCT is a non-invasive imaging technique that uses light to create detailed images of the retina. OCT can be used to detect the presence of ERM, as well as to evaluate the extent of the condition. Fluorescein angiography is a specialized imaging technique that uses a dye to highlight areas of the retina that are affected by ERM.
The treatment of ERM depends on the severity of the condition. In mild cases, treatment may not be necessary. However, in more severe cases, treatment may be necessary to prevent vision loss. The most common treatment for ERM is a surgical procedure called vitrectomy. During this procedure, the vitreous gel that fills the eye is removed and replaced with a gas or silicone oil bubble. This helps to reduce the tension on the retina and prevent further damage. In some cases, medications may be used to reduce inflammation and improve vision. Corticosteroids, such as prednisone, may be prescribed to reduce inflammation and improve vision.
Epiretinal membrane is a common condition that affects the eyes of millions of people worldwide. It is a thin, transparent layer of tissue that forms on the surface of the retina, the light-sensitive layer of tissue at the back of the eye. ERM can cause a variety of vision problems, including blurred vision, reduced contrast sensitivity, and difficulty with night vision. In some cases, ERM can lead to permanent vision loss. Diagnosis of ERM typically involves a combination of physical examination, imaging tests, and other diagnostic techniques. Treatment of ERM depends on the severity of the condition and may include surgery, medications, or a combination of both. With the latest advances in diagnosis and treatment, doctors are now better equipped to diagnose and treat ERM and help patients preserve their vision.
1.
Common intracellular toxin could help fight leukemia
2.
CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma
3.
Scholastic performance is a key concern for young cancer patients, study finds
4.
AACR: American Association for Cancer Research
5.
Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven
1.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
2.
Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions
3.
Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment
4.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
5.
Clonal Hematopoiesis and Healthy Aging: Insights, Mechanisms, and Clinical Relevance
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
2.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
3.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
4.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
5.
Advances in Modern Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation